Cargando…

Cyclin D1, Id1 and EMT in breast cancer

BACKGROUND: Cyclin D1 is a well-characterised cell cycle regulator with established oncogenic capabilities. Despite these properties, studies report contrasting links to tumour aggressiveness. It has previously been shown that silencing cyclin D1 increases the migratory capacity of MDA-MB-231 breast...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tobin, Nicholas P, Sims, Andrew H, Lundgren, Katja L, Lehn, Sophie, Landberg, Göran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192789/ https://www.ncbi.nlm.nih.gov/pubmed/21955753 http://dx.doi.org/10.1186/1471-2407-11-417

Ejemplares similares

Decreased expression of Yes-associated protein is associated with outcome in the luminal A breast cancer subgroup and with an impaired tamoxifen response
por: Lehn, Sophie, et al.
Publicado: (2014)

Effects of cyclin D(1 )gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study
por: Lundgren, Katja, et al.
Publicado: (2012)

Analysis of Cyclin D1 in Breast Cancer: A Call to Arms
por: Tobin, Nicholas P., et al.
Publicado: (2012)

Cyclin E Expression and Proliferation in Breast Cancer
por: Nielsen, Niels H., et al.
Publicado: (1998)

Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer
por: Lundgren, Katja, et al.
Publicado: (2008)

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients
por: Stendahl, M, et al.
Publicado: (2004)

Inactivation of the retinoblastoma tumour suppressor pathway in premenopausal breast cancer is associated with resistance to tamoxifen
por: Lehn, S, et al.
Publicado: (2009)

Tissue microarray analyses of G1/S-regulatory proteins in ductal carcinoma in situ of the breast indicate that low cyclin D1 is associated with local recurrence
por: Jirström, K, et al.
Publicado: (2003)

Prefoldin 1 promotes EMT and lung cancer progression by suppressing cyclin A expression
por: Wang, D, et al.
Publicado: (2017)

Cyclin A2, Rho GTPases and EMT
por: Bendris, Nawal, et al.
Publicado: (2012)

Role of cyclin D1 in breast carcinoma
por: Mohammadizadeh, Fereshteh, et al.
Publicado: (2013)

Differential expression of cytoplasmic and stromal β-arrestin-1 is associated with separate aspects of tumor behavior in breast cancer
por: Lundgren, K, et al.
Publicado: (2009)

Expression of cyclin D1, D3, E, and p27 in human renal cell carcinoma analysed by tissue microarray
por: Hedberg, Y, et al.
Publicado: (2003)

Id2 regulates the proliferation of squamous cell carcinoma in vitro via the NF-κB/Cyclin D1 pathway
por: Wang, Chuan, et al.
Publicado: (2012)

The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours
por: Lundberg, Arian, et al.
Publicado: (2019)

ID1 and ID4 Are Biomarkers of Tumor Aggressiveness and Poor Outcome in Immunophenotypes of Breast Cancer
por: Garcia-Escolano, Marta, et al.
Publicado: (2021)

Age Dependent Switching Role of Cyclin D1 in Breast Cancer
por: Rinaldi, Carmela, et al.
Publicado: (2012)

Wnt Pathway Activity in Breast Cancer Sub-Types and Stem-Like Cells
por: Lamb, Rebecca, et al.
Publicado: (2013)

Computational analysis of Cyclin D1 gene SNPs and association with breast cancer
por: Aftab, Ayesha, et al.
Publicado: (2021)

Hypoxia, Snail and incomplete epithelial–mesenchymal transition in breast cancer
por: Lundgren, K, et al.
Publicado: (2009)

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status.
por: Nielsen, N. H., et al.
Publicado: (1996)

High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
por: Ahlin, Cecilia, et al.
Publicado: (2017)

Cyclin D1 goes metabolic: Dual functions of cyclin D1 in regulating lipogenesis
por: Knudsen, Karen E.
Publicado: (2012)

Kinase independent oncogenic cyclin D1
por: Casimiro, Mathew C., et al.
Publicado: (2015)

Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients
por: Bahnassy, Abeer A, et al.
Publicado: (2004)

Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1‐pRB‐E2F1 pathway
por: Wang, Jing, et al.
Publicado: (2023)

Contribution of personalized Cyclin D1 genotype to triple negative breast cancer risk
por: Liu, Liang-Chih, et al.
Publicado: (2014)

Stromal cyclin D1 promotes heterotypic immune signaling and breast cancer growth
por: Pestell, Timothy G., et al.
Publicado: (2017)

Significance of Targeting VEGFR-2 and Cyclin D1 in Luminal-A Breast Cancer
por: N. Abdalla, Ashraf, et al.
Publicado: (2020)

An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Id1 and Id3 expression is associated with increasing grade of prostate cancer: Id3 preferentially regulates CDKN1B
por: Sharma, Pankaj, et al.
Publicado: (2012)

Cyclin K and cyclin D1b are oncogenic in myeloma cells
por: Marsaud, Véronique, et al.
Publicado: (2010)

Correction: An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Correction: An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Correction: An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Correction: An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Correction: An In Vitro Model That Recapitulates the Epithelial to Mesenchymal Transition (EMT) in Human Breast Cancer
por: Katz, Elad, et al.
Publicado: (2011)

Protein expression and gene amplification of primary cyclins (A, B(1), D(1), D(3 )and E) and secondary cyclins (C and H) in relation to prognosis in breast cancer patients
por: Husdal, A, et al.
Publicado: (2005)

RUNX1, a new regulator of EMT in breast cancer
por: Khawaled, Saleh, et al.
Publicado: (2017)

FRA-1 as a Regulator of EMT and Metastasis in Breast Cancer
por: Casalino, Laura, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ijbae0crf804br0t2qottch4oq